Literature DB >> 5505084

Partial deficiency of hypoxanthine-guanine phosphoribosyltransferase associated with gout and uric acid lithiasis.

O Sperling, M Frank, R Ophir, U A Liberman, A Adam, A de Vries.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5505084

Source DB:  PubMed          Journal:  Rev Eur Etud Clin Biol        ISSN: 0035-3019


× No keyword cloud information.
  7 in total

1.  A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout.

Authors:  J B Wyngaarden; O Sperling; F Starmer
Journal:  Trans Am Clin Climatol Assoc       Date:  1973

2.  Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man.

Authors:  R Curto; E O Voit; M Cascante
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

3.  Clinical and biochemical observations on three cases of hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  D N Bunn; I K Moss; A Nicholls; J T Scott; M L Snaith; M R Watson
Journal:  Ann Rheum Dis       Date:  1975-06       Impact factor: 19.103

4.  De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  S Brosh; P Boer; B Kupfer; A de Vries; O Sperling
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

Review 5.  Hypoxanthine-guanine phosphoribosyl transferase deficiency.

Authors:  C H de Bruyn
Journal:  Hum Genet       Date:  1976-02-29       Impact factor: 4.132

6.  The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.

Authors:  O Sperling; J B Wyngaarden; C F Starmer
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

7.  Hypoxanthine-guanine phosphoribosyltransferase variant associated with accelerated purine synthesis.

Authors:  P J Benke; N Herrick; A Hebert
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.